Table 1.
Physiological aspect involvements | Gene name | Mainly locations in the hypothalamus | Symptoms in human mutation | Phenotypes in mice mutation |
---|---|---|---|---|
Leptin-melanocortin pathway | LEPR | ARC, PVH, VMH and LHA | Early-onset obesity | Early-onset obesity |
POMC | ARC | Obesity and hyperphagia | Obesity and hyperphagia | |
NCOA1 | Widely expressed | Obesity | Hyperphagia, increased fat mass and diet-induced obesity | |
MC4R | PVH | Obesity | Obesity, hyperphagia and hyperglucemia | |
SIM1 | PVH | Obesity | Obesity and hyperphagia | |
ARNT2 | Widely expressed | Associated with BMI | Hyperphagia, abnormal glucose metabolism and excessive lipid storage | |
BDNF | PVH and VMH | Associated with BMI | Disrupted body weight and food intake | |
NTRK2 | ARC, VMH and DMH | Obesity | Obesity and hyperphagia | |
Primary cilia related | CEP19 | Widely expressed | Obesity | Obesity and hyperphagia |
ADCY3 | ARC, PVH and VMH | Associated with BMI | Disrupted body weight | |
Other genes | FTO | Widely expressed | Associated with BMI and more food intake | Reduced body fat mass (knockout) |
MYT1L | Widely expressed | Obesity | / | |
SH2B1 | Widely expressed | Obesity | Obesity and leptin resistance |
ADCY3, adenylate cyclase 3; ARC, arcuate nucleus of hypothalamus; ARNT2, Aryl hydrocarbon receptor nuclear translocator 2; BDNF, brain-derived neurotropic factor; BMI, body mass index; CEP19, centrosomal protein 19; DMH, dorsomedial hypothalamus; FTO, FTO alpha-ketoglutarate dependent dioxygenase in Homo sapiens and fat mass and obesity associated in Mus musculus; LEPR, leptin receptor; LHA, lateral hypothalamic area; MC4R, melanocortin 4 receptor; MYT1L, myelin transcription factor 1 like; NCOA1, nuclear receptor coactivator 1; NTRK2, neurotrophic receptor tyrosine kinase 2; POMC, pro-opiomelanocortin; PVH, paraventricular nucleus of the hypothalamus; SH2B1, SH2B adaptor protein 1; SIM1, single-minded 1; VMH, ventromedial hypothalamus